Hanall to conduct phase 2 trial for protein therapeutic in US
If approved, the company will conduct phase 2 trial in hepatitis C patients in the U.S. from October this year.
In the pipeline of ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
